share_log

Why NeuroBo Pharmaceuticals Is Trading Higher By Around 55%; Here Are 25 Stocks Moving Premarket

Why NeuroBo Pharmaceuticals Is Trading Higher By Around 55%; Here Are 25 Stocks Moving Premarket

為什麼NeuroBo製藥公司的股價上漲了55%左右;以下是盤前25只股票的走勢
Benzinga Real-time News ·  2022/09/15 07:56
Gainers
贏家
NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) rose 54.6% to $26.07 in pre-market trading after the company entered into an exclusive license agreement with Dong-A. Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) shares rose 28.6% to $0.2765 in pre-market trading. Sonnet BioTherapeutics, last month, posted a Q3 loss of $0.13 per share. Aditxt, Inc. (NASDAQ:ADTX) rose 24.9% to $14.28 in pre-market trading. Aditxt announced a 1-for-50 reverse stock split effective on September 14, 2022. Fast Radius, Inc. (NASDAQ:FSRD) rose 19.4% to $0.6260 in pre-market trading. The company, last month, posted upbeat quarterly results. Addentax Group Corp. (NASDAQ:ATXG) shares rose 16.3% to $5.56 in pre-market trading after jumping...
NeuroBo製藥公司納斯達克(Sequoia Capital:NRBO)在盤前交易中上漲54.6%,至26.07美元,此前該公司與東A簽訂了獨家許可協議。 十四行詩生物治療控股公司納斯達克股價在...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論